Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 3546 entries
View as:

Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02215096 Org: User:
Start: 11/13/14 End: 10/03/19 Due: 10/03/20

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Phase: N/A Priority: Normal
NCT ID: NCT00291889 Org: User:
Start: 07/31/04 End: 05/31/05 Due: 05/31/06

Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00397215 Org: User:
Start: 11/17/06 End: 09/14/09 Due: 09/14/10

Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00479856 Org: User:
Start: 11/30/07 End: 03/31/10 Due: 03/31/11

A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Phase: N/A Priority: Normal
NCT ID: NCT01894022 Org: User:
Start: 01/23/14 End: 11/18/15 Due: 11/18/16

Duration of Protection: GSK DTaP Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT02447978 Org: User:
Start: 02/28/15 End: 06/30/15 Due: 06/30/16

Korean Practice Patterns for Screening PCA(Prostate Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT01371513 Org: User:
Start: 05/31/10 End: 06/30/11 Due: 06/30/12

GSK2190915A - Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT02224521 Org: User:
Start: 04/20/09 End: 06/08/10 Due: 06/08/11

Migraine Study in Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT00843024 Org: User:
Start: 12/31/08 End: 06/30/10 Due: 06/30/11

Bioequivalence Study for Terbinafine 250 mg

Phase: N/A Priority: Normal
NCT ID: NCT01772212 Org: User:
Start: 02/24/11 End: 03/15/11 Due: 03/15/12

Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01009060 Org: User:
Start: 12/01/09 End: 08/10/11 Due: 08/10/12

A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure

Phase: N/A Priority: Normal
NCT ID: NCT02135861 Org: User:
Start: 07/30/14 End: 02/22/17 Due: 02/22/18

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Phase: N/A Priority: Normal
NCT ID: NCT00517946 Org: User:
Start: 03/31/07 End: 04/30/07 Due: 04/30/08

Neisseria Meningitidis Burden of Disease Study

Phase: N/A Priority: Normal
NCT ID: NCT01730391 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01602900 Org: User:
Start: 11/22/11 End: 04/12/12 Due: 04/12/13

Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00711776 Org: User:
Start: 04/10/08 End: 08/17/08 Due: 08/17/09

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)

Phase: N/A Priority: Normal
NCT ID: NCT00197262 Org: User:
Start: 08/31/05 End: 10/31/05 Due: 10/31/06

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

Phase: N/A Priority: Normal
NCT ID: NCT00907777 Org: User:
Start: 06/23/09 End: 10/05/09 Due: 10/05/10

Investigation of Topical SB705498 on Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01673529 Org: User:
Start: 07/17/12 End: 10/04/12 Due: 10/04/13

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00102726 Org: User:
Start: 02/28/05 End: 02/28/07 Due: 02/28/08

JCP Study of Investigation of Patient Background Characteristics

Phase: N/A Priority: Normal
NCT ID: NCT01332474 Org: User:
Start: 05/31/10 End: 08/31/10 Due: 08/31/11

Dose Ranging Study of Albiglutide in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01098461 Org: User:
Start: 04/30/10 End: 05/31/11 Due: 05/31/12

Study to Assess Cardiac Conduction of GSK1349572

Phase: N/A Priority: Normal
NCT ID: NCT00996021 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

Phase: N/A Priority: Normal
NCT ID: NCT00992784 Org: User:
Start: 10/15/09 End: 05/27/10 Due: 05/27/11

Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls

Phase: N/A Priority: Normal
NCT ID: NCT05393076 Org: User:
Start: 07/19/22 End: 12/06/22 Due: 12/06/23